The Food and Drug Administration on Tuesday authorized a booster dose of Pfizer-BioNTech’s Covid-19 vaccine for children ages 5-11, expanding access to boosters to the youngest age group yet after the agency allowed children ages 12-15 to get a booster earlier this year.
READ MORE: [ Ссылка ]
Stay Connected
Forbes on Facebook: [ Ссылка ]
Forbes Video on Twitter: [ Ссылка ]
Forbes Video on Instagram: [ Ссылка ]
More From Forbes: [ Ссылка ]
